Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaflex for Peyronie's Disease (IMPRESS II)
NCT01221597Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Sep 2010
- Primary completion
- Apr 2012
- Modality
- Therapeutic Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of collagenase clostridium histolyticum in Peyronie's disease, sponsored by Endo International plc. Started Sep 2010; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on NCT01221597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01221597.